Brainstorm Cell Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2002 | — | $53.0K | — |
| FY2003 | — | $21.0K | — |
| FY2004 | — | $-31.0K | — |
| FY2005 | — | $704.0K | — |
| FY2006 | — | $-7.9M | — |
| FY2007 | — | $-2.4M | — |
| FY2008 | — | $-2.1M | — |
| FY2009 | — | $-1.7M | $1.0K |
| FY2010 | — | $-459.0K | $749.0K |
| FY2011 | — | $1.5M | $3.7M |
| FY2012 | — | $4.0M | $843.0K |
| FY2013 | — | $2.7M | $3.5M |
| FY2014 | — | $6.7M | $4.3M |
| FY2015 | — | $14.1M | $428.0K |
| FY2016 | — | $9.9M | $547.0K |
| FY2017 | — | $5.9M | $2.5M |
| FY2018 | — | $5.0M | $942.0K |
| FY2019 | — | $-12.2M | $536.0K |
| FY2020 | — | $35.5M | $37.8M |
| FY2021 | — | $19.3M | $18.9M |
| FY2022 | — | $-3.0M | $772.0K |
| FY2023 | — | $-4.9M | $1.3M |
| FY2024 | — | $-7.8M | $187.0K |
| FY2025 | — | $-10.0M | $29.0K |